Achelios Therapeutics, Inc.
Topically delivered small molecules for pain and inflammation treatment
- Sector
- Biotech
- Headquarters
- CHAPEL HILL, NC
- Founded
- 2012
- Latest Form D
- $350K, Apr 2016
- Total capital
- $2.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $2.2M
- 2 Form D · last Apr 2016
- 126 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 14 pending · first 2014
- Rank in peer group#339 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$350K
- Private capital raisedForm D · SEC · 1st filing$1.9M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#339 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Crist J. FrangakisResearcherExecutive Officer, DirectorLinked by 1 patent
- Jerry J. RosenblattDirectorNamed in SEC Form D filings
- Ron J. VeredDirectorNamed in SEC Form D filings
- William J. BauerDirectorNamed in SEC Form D filings
- William J. DickieDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 17- PendingMethods And Compositions For Treating Migraine And Conditions Associated With PainUSPTOApplication 17341029
- GrantedTopical Anti-inflammatory CompositionsUSPTOUS 11,229,617
- GrantedMethods And Compositions For Treating Migraine And Conditions Associated With PainUSPTOUS 11,026,882
Show all 17 patent records
- Methods And Compositions For Treating Migraine And Conditions Associated With PainApr 28, 2022 · Application 17341029Pending
- Topical Anti-inflammatory CompositionsJan 25, 2022 · US 11,229,617Granted
- Methods And Compositions For Treating Migraine And Conditions Associated With PainJun 8, 2021 · US 11,026,882Granted
- Topical Anti-inflammatory CompositionsDec 5, 2019 · Application 16332124Pending
- Methods And Compositions For Treating And Preventing Trigeminal Autonomic Cephalgias, Migraine, And Vascular ConditionsApr 11, 2019 · Application 16040043Pending
- Methods And Compositions For Treating Peripheral NeuropathyDec 27, 2018 · Application 16062353Pending
- Sprayable Analgesic CompositionsSep 27, 2018 · Application 15524455Pending
- Methods And Compositions For Treating Migraine And Conditions Associated With PainSep 21, 2017 · Application 15532425Pending
- Topical Ketoprofen CompositionSep 2, 2014 · US 8,822,537Granted
- Methods And Compositions For Treating Peripheral NeuropathyApplication PCTUS2016067276Pending
- Topical Antifungal CompositionsApplication PCTUS2016055978Pending
- Methods And Compositions For Treating Peripheral NeuropathyApplication 62268007Pending
- Methods And Compositions For Treating Migraine And Conditions Associated With PainApplication PCTUS2015063220Pending
- Sprayable Analgesic CompositionsApplication PCTUS2015058927Pending
- Methods And Compositions For Treating Migraine And Conditions Associated With PainApplication 62085943Pending
- Topical Ketoprofen CompositionApplication PCTUS2013061403Pending
- Topical Anti-inflammatory CompositionsApplication PCTUS2017051560Pending
Related companies, and why
- Lipocine Inc.Similar federal contract value in Biotech · null in contracts
- ADMA PLASMA BIOLOGICS, INC.Similar federal contract value in Biotech · null in contracts
- Pahr Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Pulmatrix, Inc.Similar federal contract value in Biotech · null in contracts
- ImmunoVec, Inc.Similar federal contract value in Biotech · null in contracts
- Aurinia Pharmaceuticals Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .